Real-world outcomes of a placenta-based tissue product versus standard of care for lower extremity diabetic ulcers: A Medicare cohort study

Written By Dianne Trim

Authors

William Tettelbach, MD, FACP, FIDSA, FUHM, MAPWCA¹ ² ³ ⁴*
Travis Tucker, MA, MBA⁵
Kimberly Kot, MAS⁶

Corresponding Author: tarpon@xmission.com

Affiliations

¹ RestorixHealth, Metairie, LA, US.

² President, American Professional Wound Care Association (APWCA), Milwaukee, WI, US.

³ Adjunct Assistant Professor of Undersea & Hyperbaric Medicine, Duke University School of Medicine, Durham, NC, US.

⁴ Adjunct Professor of Podiatric Medicine & Surgery, Western University of Health Sciences, Pomona, CA, US.

⁵ Owner, Principal Consultant, Woodside Analytics, LLC, St. Petersburg, FL, US.

⁶ Medical Writing Consultant, El Paso, TX, US.

Dianne Trim
Previous

Comparative Effectiveness of Placental Allografts in the Treatment of Diabetic Lower Extremity Ulcers and Venous Leg Ulcers in U.S. Medicare Beneficiaries
Next

Calciphylaxis-associated pannicular wounds in end-stage renal disease: Recurrent disease, massive adiposenecrosis, and eventual resolution through multidisciplinary management